Cited 0 times in
A multi-institutional, single-arm, phase II trial of neoadjuvant modified-FOLFIRINOX for resectable pancreatic ductal adenocarcinoma
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.